Company Analysis
Sign in

Stablecoin Development Corporation (SDEV)

NYSE: SDEV · Pharmaceutical Preparations · Emeryville, CA · filing with the SEC since 2007
Full chart Alerts Compare
Grade3.2
◀ Past 1.7● Present 1.4▶ Future 5.7
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

11 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Stablecoin Development Corporation’s names, not what it holds today.

Patents granted
11
11 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
18
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'08'09'10'11'12'13'14'15'16'17
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
NovaBay Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
11 granted
17 published
NovaBay Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Apr 18, 20179,625,744Contact lens cleaning system with insulationOpticsNovaBay Pharmaceuticals, Inc.
Feb 2, 20169,248,117Substituted N,N-dihaloamines as antimicrobialsPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Oct 7, 20148,851,091Contact lens cleaning system with monitorBasic materials chemistryNovaBay Pharmaceuticals, Inc.
May 20, 20148,729,112Antimicrobial haloalkyl heterocycle compoundsOrganic fine chemistryNovaBay Pharmaceuticals, Inc.
May 13, 20148,722,715Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositionsOrganic fine chemistryNovaBay Pharmaceuticals, Inc.
Apr 9, 20138,415,497N-halogenated amino compounds and derivativesOrganic fine chemistryNovaBay Pharmaceuticals, Inc.
Oct 2, 20128,278,482Antimicrobial N-chlorinated compositionsPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Feb 22, 20117,893,109N,N-dihalogenated amino acids and derivativesPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Dec 7, 20107,846,971N-halogenated amino acids, N,N-dihalogenated amino acids and derivatives; compositions and methods of using themPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Dec 9, 20087,462,361N,N-dihalogenated amino acids and derivativesPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Feb 23, 20172017/0051842Magnetic Valve SystemMechanical elementsNovaBay Pharmaceuticals, Inc.
Dec 1, 20162016/0346324Method of Inactivating Bacterial Lipases Using Oxidative Chlorine SpeciesPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Nov 17, 20162016/0331779METHOD OF INACTIVATING TOXINS USING OXIDATIVE CHLORINE SPECIESPharmaceuticalsNovaBay Pharmaceuticals, Inc.
Apr 30, 20152015/0118108Contact Lens Cleaning System With InsulationOpticsNovaBay Pharmaceuticals, Inc. · patent 9,625,744 granted from it
Jan 8, 20152015/0007860Contact Lens Cleaning System With MonitorBasic materials chemistryNovaBay Pharmaceuticals, Inc.
Aug 14, 20142014/0227201Antimicrobial Gel FormulationsOrganic fine chemistryNovaBay Pharmaceuticals, Inc.
Apr 3, 20142014/0094495Antimicrobial Haloalkyl Heterocycle CompoundsOrganic fine chemistryNovaBay Pharmaceuticals, Inc. · patent 8,729,112 granted from it
Nov 8, 20122012/0282351System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino AcidsPharmaceuticalsNovaBay Pharmaceuticals, Inc.
May 24, 20122012/0129793Antimicrobial Polyether and Polyol CompoundsPharmaceuticalsNovaBay Pharmaceuticals, Inc. · patent 9,248,117 granted from it
Jun 23, 20112011/0151025Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary InfectionsPharmaceuticalsNovaBay Pharmaceuticals, Inc.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton SDEV · research, not advice